D. E. Shaw & Co., Inc.
- SEC CIK
- 0001009207
- Latest filing
- Aug 14, 2026
RCKT holding history
Rocket Pharmaceuticals, Inc. in every 13F filed by D. E. Shaw & Co., Inc., including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
RCKT overviewAll 13F holders of RCKTFull Q2 2026 holdings
- Shares (Q2 2026)
- 950,552
- Value
- $3.25M
- % of portfolio
- <0.1%
- Quarters held
- 15
- Since Q1 2021
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q2 2026 | 950,552 | $3.25M | <0.1% | −1,219,073−56.2% | Reduced | Holders |
| Q1 2026 | 2,169,625 | $7.77M | <0.1% | −470,893−17.8% | Reduced | Holders |
| Q4 2025 | 2,640,518 | $9.27M | <0.1% | +450,768+20.6% | Added | Holders |
| Q3 2025 | 2,189,750 | $7.14M | <0.1% | +1,196,925+120.6% | Added | Holders |
| Q2 2025 | 992,825 | $2.43M | <0.1% | +992,825 | New | Holders |
| Q3 2023 | 0 | $0 | 0.0% | −42,215−100.0% | Sold out | Holders |
| Q2 2023 | 42,215 | $838.8K | <0.1% | −43,530−50.8% | Reduced | Holders |
| Q1 2023 | 85,745 | $1.47M | <0.1% | −96,417−52.9% | Reduced | Holders |
| Q4 2022 | 182,162 | $3.56M | <0.1% | −266,180−59.4% | Reduced | Holders |
| Q3 2022 | 448,342 | $7.16M | <0.1% | +260,041+138.1% | Added | Holders |
| Q2 2022 | 188,301 | $2.59M | <0.1% | −3,211−1.7% | Reduced | Holders |
| Q1 2022 | 191,512 | $3.04M | <0.1% | +40,018+26.4% | Added | Holders |
| Q4 2021 | 151,494 | $3.31M | <0.1% | −33,940−18.3% | Reduced | Holders |
| Q3 2021 | 185,434 | $5.54M | <0.1% | −14,584−7.3% | Reduced | Holders |
| Q2 2021 | 200,018 | $8.86M | <0.1% | −106,232−34.7% | Reduced | Holders |
| Q1 2021 | 306,250 | $13.6M | <0.1% | – | – | Holders |
Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.